颈动脉支架置入与机械取栓治疗伴串联病变的大血管闭塞性缺血性卒中的功能与安全性结局
该多中心国际横断面研究纳入2015年1月1日至2020年12月31日美国与西班牙17个卒中中心的623例急性前循环串联病变患者,比较机械取栓时颈动脉支架置入(CAS组363例)与未支架置入(非支架组260例)的结局。校正混杂因素后,CAS组90天功能独立(aOR 1.67,95%CI 1.20-2.40,P=0.007)、mRS有利偏移(aOR 1.46,95%CI 1.02-2.10,P=0.04)和成功再灌注(aOR 1.70,95%CI 1.02-3.60,P=0.002)的几率更高;症状性颅内出血(aOR 0.90,95%CI 0.46-2.40,P=0.87)和90天死亡(aOR 0.78,95%CI 0.50-1.20,P=0.27)两组相似。作者认为,取栓时对颈部病变行CAS与功能结局和再灌注率改善相关,且不增加症状性颅内出血和死亡风险。
要点
- 伴串联病变的前循环大血管闭塞取栓时行颈动脉支架置入,90天功能独立(mRS 0-2)几率更高:aOR 1.67(95%CI 1.20-2.40,P=0.007)。
- 颈动脉支架置入组成功再灌注(mTICI≥2b)几率更高:aOR 1.70(95%CI 1.02-3.60,P=0.002)。
- 颈动脉支架置入不增加症状性颅内出血:aOR 0.90(95%CI 0.46-2.40,P=0.87);90天死亡两组相似:aOR 0.78(95%CI 0.50-1.20,P=0.27)。
- 颈动脉支架置入组mRS有利偏移几率更高:aOR 1.46(95%CI 1.02-2.10,P=0.04)。
- 预设亚组中90天功能结局和症状性颅内出血未见异质性。
适用人群与场景
- 年龄18岁及以上、因颅内闭塞接受血管内治疗、且取栓前CT血管造影、MR血管造影或数字减影血管造影显示颈内动脉颅外段狭窄>50%的急性前循环串联病变患者。
- 2015年1月1日至2020年12月31日在美国和西班牙17个卒中中心连续纳入。
诊断标准与关键阈值
- 串联病变定义为颅内大血管闭塞合并颈内动脉颅外段狭窄或闭塞。
- 颈内动脉颅外段狭窄>50%需经取栓前CT血管造影、MR血管造影或数字减影血管造影证实。
- 功能独立定义为90天改良Rankin量表(mRS)评分0-2分。
- 成功再灌注定义为改良脑梗死溶栓(mTICI)评分≥2b。
研究设计与关键结果
- 多中心国际横断面研究,纳入623例(共筛查685例)急性前循环串联病变患者,平均(SD)年龄67(12.2)岁,406例(65.2%)男性;CAS组363例(58.4%),非支架组260例(41.6%)。
- CAS组与非支架组比较:心房颤动比例更低(38例[10.6%] vs 49例[19.2%],P=0.002);数字减影血管造影示术前颈部狭窄90%-99%比例更高(107例[32.2%] vs 42例[20.5%],P<0.001);动脉粥样硬化性疾病比例更高(296例[82.0%] vs 194例[74.6%],P=0.003);美国国立卫生研究院卒中量表评分中位数(IQR)更低(15[10-19] vs 17[13-21],P<0.001);静脉溶栓率和卒中时间指标相似。
- 校正混杂因素后,CAS组相比非支架组:90天功能独立aOR 1.67(95%CI 1.20-2.40,P=0.007);mRS有利偏移aOR 1.46(95%CI 1.02-2.10,P=0.04);成功再灌注aOR 1.70(95%CI 1.02-3.60,P=0.002)。
- 症状性颅内出血aOR 0.90(95%CI 0.46-2.40,P=0.87);90天死亡aOR 0.78(95%CI 0.50-1.20,P=0.27)。
- 预设亚组中90天功能结局和症状性颅内出血未见异质性。
证据类型、等级与局限
- 证据类型:多中心国际横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在伴串联病变的大血管闭塞性卒中患者机械取栓过程中,对颈部病变行颈动脉支架置入与功能结局和再灌注率改善相关,且不增加症状性颅内出血和死亡风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Approximately 10% to 20% of large vessel occlusion (LVO) strokes involve tandem lesions (TLs), defined as concomitant intracranial LVO and stenosis or occlusion of the cervical internal carotid artery. Mechanical thrombectomy (MT) may benefit patients with TLs; however, optimal management and procedural strategy of the cervical lesion remain unclear.
OBJECTIVE: To evaluate the association of carotid artery stenting (CAS) vs no stenting and medical management with functional and safety outcomes among patients with TL-LVOs.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included consecutive patients with acute anterior circulation TLs admitted across 17 stroke centers in the US and Spain between January 1, 2015, and December 31, 2020. Data analysis was performed from August 2021 to February 2022. Inclusion criteria were age of 18 years or older, endovascular therapy for intracranial occlusion, and presence of extracranial internal carotid artery stenosis (>50%) demonstrated on pre-MT computed tomography angiography, magnetic resonance angiography, or digital subtraction angiography.
EXPOSURES: Patients with TLs were divided into CAS vs nonstenting groups.
MAIN OUTCOMES AND MEASURES: Primary clinical and safety outcomes were 90-day functional independence measured by a modified Rankin Scale (mRS) score of 0 to 2 and symptomatic intracranial hemorrhage (sICH), respectively. Secondary outcomes were successful reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2b), discharge mRS score, ordinal mRS score, and mortality at 90 days.
RESULTS: Of 685 patients, 623 (mean [SD] age, 67 [12.2] years; 406 [65.2%] male) were included in the analysis, of whom 363 (58.4%) were in the CAS group and 260 (41.6%) were in the nonstenting group. The CAS group had a lower proportion of patients with atrial fibrillation (38 [10.6%] vs 49 [19.2%], P = .002), a higher proportion of preprocedural degree of cervical stenosis on digital subtraction angiography (90%-99%: 107 [32.2%] vs 42 [20.5%], P < .001) and atherosclerotic disease (296 [82.0%] vs 194 [74.6%], P = .003), a lower median (IQR) National Institutes of Health Stroke Scale score (15 [10-19] vs 17 [13-21], P < .001), and similar rates of intravenous thrombolysis and stroke time metrics when compared with the nonstenting group. After adjustment for confounders, the odds of favorable functional outcome (adjusted odds ratio [aOR], 1.67; 95% CI, 1.20-2.40; P = .007), favorable shift in mRS scores (aOR, 1.46; 95% CI, 1.02-2.10; P = .04), and successful reperfusion (aOR, 1.70; 95% CI, 1.02-3.60; P = .002) were significantly higher for the CAS group compared with the nonstenting group. Both groups had similar odds of sICH (aOR, 0.90; 95% CI, 0.46-2.40; P = .87) and 90-day mortality (aOR, 0.78; 95% CI, 0.50-1.20; P = .27). No heterogeneity was noted for 90-day functional outcome and sICH in prespecified subgroups.
CONCLUSIONS AND RELEVANCE: In this multicenter, international cross-sectional study, CAS of the cervical lesion during MT was associated with improvement in functional outcomes and reperfusion rates without an increased risk of sICH and mortality in patients with TLs.
参考来源
- Farooqui M, Zaidat OO, Hassan AE, et al. Functional and Safety Outcomes of Carotid Artery Stenting and Mechanical Thrombectomy for Large Vessel Occlusion Ischemic Stroke With Tandem Lesions. JAMA Netw Open. 2023. PMID: 36857054. doi:10.1001/jamanetworkopen.2023.0736
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。